Data / Drug companies / Evonik Corporation
Evonik Corporation: 14 products in the FDA NDC directory, labeler code 62128
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Evonik Corporation (labeler code 62128) lists 14 products in the FDA National Drug Code Directory. By type: 14 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on December 13, 2024.
The request: Watch Evonik Corporation (FDA labeler code 62128): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 62128
- Products in commercial distribution
- 14
- Packages
- 16
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- June 25, 1968
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 12 | 85.7% |
| Export only | 2 | 14.3% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 14 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 11 | 78.6% |
| Liquid | 2 | 14.3% |
| Suspension | 1 | 7.1% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Gemcitabine hydrochloride | 62128-0383 | Powder | Export only | December 13, 2024 |
| Mgl-3196 | 62128-0396 | Powder | Bulk ingredients | March 14, 2024 |
| Vonoprazan fumarate | 62128-0397 | Powder | Bulk ingredients | November 21, 2023 |
| Linzagolix choline | 62128-0395 | Powder | Export only | June 14, 2022 |
| Baloxavir marboxil | 62128-0394 | Powder | Bulk ingredients | December 2, 2021 |
| Lubabegron fumarate | 62128-0393 | Powder | Bulk ingredients | November 6, 2018 |
| Alectinib hcl | 62128-0384 | Powder | Bulk ingredients | December 11, 2015 |
| Enzalutamide | 62128-0388 | Powder | Bulk ingredients | September 1, 2015 |
| Duloxetine hydrochloride | 62128-0386 | Powder | Bulk ingredients | August 3, 2004 |
| Tadalafil | 62128-0385 | Powder | Bulk ingredients | November 26, 2003 |
| Tilmicosin aqueous | 62128-0389 | Liquid | Bulk ingredients | December 2, 1996 |
| Ractopamine hydrochloric acid | 62128-0392 | Suspension | Bulk ingredients | December 1, 1992 |
| Tilmicosin | 62128-0390 | Powder | Bulk ingredients | March 2, 1992 |
| Tylosin intermediate | 62128-0391 | Liquid | Bulk ingredients | June 25, 1968 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.